Scott D O, Ghosh A, Di L, Maurer T S
Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Cambridge, MA 02139, United States.
Department of Mechanism Based Drug Disposition, Jannsen Pharmaceuticals, Spring House, PA 18901, United States.
Pharmacol Res. 2017 Mar;117:94-102. doi: 10.1016/j.phrs.2016.11.028. Epub 2016 Nov 24.
Although often overlooked, passive mechanisms can lead to significant accumulation or restriction of drugs to intracellular sites of drug action. These mechanisms include lipoidal diffusion of ionized species and pH partitioning according to the electrochemical potential and to pH gradients that exist across subcellular compartments, respectively. These mechanisms are increasingly being exploited in the design of safe and effective drugs for the treatment of a wide variety of diseases. In this work, the authors review these efforts and the associated passive mechanisms of cellular drug permeation. A generic mathematical model of the cell is provided and used to illustrate concepts relevant to steady-state intracellular distribution. Finally, the authors review methods for estimating determinant parameters and measuring the net effect at the level of unbound intracellular drug concentrations.
尽管常常被忽视,但被动机制可导致药物在细胞内药物作用部位显著蓄积或受限。这些机制分别包括离子化物质的脂类扩散以及根据跨亚细胞区室存在的电化学势和pH梯度进行的pH分配。在设计用于治疗多种疾病的安全有效药物时,这些机制正越来越多地得到应用。在这项工作中,作者回顾了这些研究以及细胞药物渗透的相关被动机制。提供了一个通用的细胞数学模型,并用于阐释与稳态细胞内分布相关的概念。最后,作者回顾了估算决定因素参数以及在未结合细胞内药物浓度水平测量净效应的方法。